WEST CHESTER, Ohio, July 31 /PRNewswire-FirstCall/ -- AtriCure, Inc.
(Nasdaq: ATRC), a medical device company and a leader in cardiac surgical
ablation systems, today announced that it will present at the following
investor conferences during August:
-- The BMO Focus on Healthcare Conference, Wednesday, August 6, 2008 at
the Millennium Broadway Hotel in New York. David J. Drachman, President
and Chief Executive Officer, is scheduled to present at 9:00 a.m.
-- The Canaccord Adams Global Growth Conference, Wednesday, August 13,
2008 at the Intercontinental Hotel in Boston. Mr. Drachman is scheduled
to present at 10:30 a.m. Eastern time.
Both presentations will be available for replay for 30 days following the presentations at http://www.atricure.com/Investor_Relations
About AtriCure, Inc.
AtriCure, Inc. is a medical device company and a leader in developing,
manufacturing and selling innovative cardiac surgical ablation systems
designed to create precise lesions, or scars, in cardiac, or heart, tissue.
Medical journals have described the adoption by leading cardiothoracic
surgeons of the AtriCure Isolator(R) bipolar ablation system as a treatment
alternative during open-heart surgical procedures to create lesions in
cardiac tissue to block the abnormal electrical impulses that cause atrial
fibrillation, or AF, a rapid, irregular quivering of the upper chambers of
the heart. Additionally, medical journals and leading cardiothoracic
surgeons have described the AtriCure Isolator(R) system as a promising
treatment alternative for patients who may be candidates for sole-therap
|SOURCE AtriCure, Inc.|
Copyright©2008 PR Newswire.
All rights reserved